Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher? MarketBeat Source link
Previewing the 2025 SDPA Annual Summer Dermatology Conference: What to Expect Dermatology Times Source link
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced BioSpace Source link
Exeter Wins £3.3M Grant for Eczema Research Mirage News Source link